C₁₆H₁₃ClN₂O (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 284.072 |
| P3780 | active ingredient in | ... | Q47521476 (Diastat) | Diastat |
| P3780 | active ingredient in | ... | Q47522264 (Valium) | Valium |
| P233 | canonical SMILES | String | CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 | ??? |
| P373 | Commons category | String | Diazepam | ??? |
| P1343 | described by source | ... | Q316572 (Opium Law) | Opium Law |
| P703 | found in taxon | ... | Q10998 (potato) | potato |
| P703 | found in taxon | ... | Q11006 (soybean) | soybean |
| P703 | found in taxon | ... | Q11575 (maize) | maize |
| P703 | found in taxon | ... | Q131226 (Lens culinaris) | Lens culinaris |
| P703 | found in taxon | ... | Q161426 (Oryza sativa) | Oryza sativa |
| P703 | found in taxon | ... | Q132734 (Fagopyrum esculentum) | Fagopyrum esculentum |
| P703 | found in taxon | ... | Q161098 (Triticum aestivum) | Triticum aestivum |
| P703 | found in taxon | ... | Q311677 (Physalis angulata) | Physalis angulata |
| P703 | found in taxon | ... | Q160114 (Mentha spicata) | Mentha spicata |
| P703 | found in taxon | ... | Q390456 (Agaricus) | Agaricus |
| P703 | found in taxon | ... | Q15978631 (Homo sapiens) | Homo sapiens |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Diazepam-from-xtal-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q117060 (spasticity) | spasticity |
| P2175 | medical condition treated | ... | Q170082 (psychosis) | psychosis |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q544006 (anxiety disorder) | anxiety disorder |
| P2175 | medical condition treated | ... | Q741713 (panic disorder) | panic disorder |
| P2175 | medical condition treated | ... | Q980709 (status epilepticus) | status epilepticus |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P2175 | medical condition treated | ... | Q3184856 (substance abuse) | substance abuse |
| P361 | part of | ... | Q14882461 (diazepam binding) | diazepam binding |
| P129 | physically interacts with | ... | Q4734884 (Adrenoceptor alpha 1A) | Adrenoceptor alpha 1A |
| P129 | physically interacts with | ... | Q5512777 (Gamma-aminobutyric acid type A receptor subunit alpha4) | Gamma-aminobutyric acid type A receptor subunit alpha4 |
| P129 | physically interacts with | ... | Q5520260 (Gamma-aminobutyric acid type A receptor subunit alpha1) | Gamma-aminobutyric acid type A receptor subunit alpha1 |
| P129 | physically interacts with | ... | Q21113297 (Gamma-aminobutyric acid type A receptor subunit delta) | Gamma-aminobutyric acid type A receptor subunit delta |
| P129 | physically interacts with | ... | Q21113305 (Gamma-aminobutyric acid type A receptor subunit gamma2) | Gamma-aminobutyric acid type A receptor subunit gamma2 |
| P129 | physically interacts with | ... | Q21113312 (Gamma-aminobutyric acid type A receptor subunit beta3) | Gamma-aminobutyric acid type A receptor subunit beta3 |
| P129 | physically interacts with | ... | Q21113314 (Gamma-aminobutyric acid type A receptor subunit beta2) | Gamma-aminobutyric acid type A receptor subunit beta2 |
| P129 | physically interacts with | ... | Q21113326 (Gamma-aminobutyric acid type A receptor subunit gamma1) | Gamma-aminobutyric acid type A receptor subunit gamma1 |
| P129 | physically interacts with | ... | Q21113337 (Gamma-aminobutyric acid type A receptor subunit theta) | Gamma-aminobutyric acid type A receptor subunit theta |
| P129 | physically interacts with | ... | Q21114574 (Gamma-aminobutyric acid type A receptor subunit beta1) | Gamma-aminobutyric acid type A receptor subunit beta1 |
| P129 | physically interacts with | ... | Q21114578 (Gamma-aminobutyric acid type A receptor subunit alpha3) | Gamma-aminobutyric acid type A receptor subunit alpha3 |
| P129 | physically interacts with | ... | Q21114582 (Gamma-aminobutyric acid type A receptor subunit alpha2) | Gamma-aminobutyric acid type A receptor subunit alpha2 |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P443 | pronunciation audio | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/LL-Q33810%20%28ori%29-Psubhashish-%E0%AC%A1%E0%AC%BE%E0%AC%8F%E0%AC%9C%E0%AD%87%E0%AC%AA%E0%AC%BE%E0%AC%AE.wav | ??? |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q432083 (intramuscular injection) | intramuscular injection |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P636 | route of administration | ... | Q1344580 (enteral administration) | enteral administration |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q421930 (mirtazapine) | mirtazapine |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q420383 (primidone) | primidone |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q7553347 (sodium oxybate) | sodium oxybate |
| P769 | significant drug interaction | ... | Q55186498 ((±)-thiopental) | (±)-thiopental |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P9989 | stylized name | String | diazePAM | ??? |
| P279 | subclass of | ... | Q70702 (alkaloid) | alkaloid |
| P279 | subclass of | ... | Q83871 (benzodiazepine drug) | benzodiazepine drug |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q62903 (anxiolytic) | anxiolytic |
| P2868 | subject has role | ... | Q83871 (benzodiazepine drug) | benzodiazepine drug |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q575136 (antiemetic) | antiemetic |
| P2868 | subject has role | ... | Q17164853 (GABAA receptor positive allosteric modulators) | GABAA receptor positive allosteric modulators |
| P2868 | subject has role | ... | Q50377192 (hypnotics and sedatives) | hypnotics and sedatives |
| P2868 | subject has role | ... | Q50429823 (anesthesia adjuvants) | anesthesia adjuvants |
| P2868 | subject has role | ... | Q50430093 (central muscle relaxants) | central muscle relaxants |
| P2868 | subject has role | ... | Q50430244 (intravenous anesthetics) | intravenous anesthetics |
| P2868 | subject has role | ... | Q50430260 (GABA Modulators) | GABA Modulators |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | diazepamum | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | diazepam | ??? |
Why not click here or view trends?
log id: None